ã2022幎4æ23æ¥ããã£ãªãã³ã代衚ããããŒããªãŸãŒãã»ã»ããæ9æ30åçºã®PR431䟿ã§ããã©ãžãããã©å°ççŽ3æéã»ã©ã§ãåœå
ç·PR1861䟿ã«ä¹ãæããŠã18æ25åã«å°çããäºå®ã ãäœãäœã§ãçŽè¡äŸ¿ã§ãšèãã人ãå€ããã4æã®æç°ããã»ããžã®çŽè¡äŸ¿ã¯å
ã2æ¬ã®ã¿ã5æãçŽè¡äŸ¿ã¯2æ¬ã ãã«ãªãããã ãããã§äžæ¹ã®äžå®ã¯æ®ããã®ã®ãããã©ä¹ãæãã«ãã£ã¬ã³ãžããããšã«ãªã£ãã
ãåºçº2æéåã®æ7æ30åã«ã¯ãã§ãã¯ã€ã³ã«ãŠã³ã¿ãŒã«å°çããå¿
èŠãããããã京ææç°é§
åã®ããã«ãªããã¢ã³ãã«åæ³ãã6æ40åçºã®ç©ºæž¯éè¿ãã¹ã«ä¹è»ããã
ããããŸã§ã®äºåæºåã¯ã24æéåã«ãã£ãªãã³èªç©ºWEBãã§ãã¯ã€ã³ãæžãŸãã矜ç°ç©ºæž¯ç¬¬1ã¿ãŒããã«ã§RT-PCRæ€æ»(æšäžã°ã«ãŒã)ã矜ç°ç©ºæž¯ç¬¬2ã¿ãŒããã«ã§æåå®æ§æ€æ»(æšäžã°ã«ãŒã)ãæžãŸãé°æ§èšŒæãååŸããã念ã®ãã2çš®é¡ã®æ€æ»ãåããããã®åŸãå°ãé£æ床ã®é«ãOneHealthPassãžã®ç»é²ã«å
¥ããã¯ã¯ãã³æ¥çš®èšŒæãé°æ§èšŒæã®ãã¡ã€ã«ã¢ãããæ±ãããããã¹ããŒããã©ã³ã«ã¯ãTRAZEã¢ããªã®å
¥åãå®è¡ãé¡åçãå
¥ããã
ããã§ãã¯ã€ã³ã«å¿
èŠãªãã¯ã¯ãã³æ¥çš®èšŒæ(åžåºçºæçºè¡)ãCOVID-19(æ°åã³ãããŠã£ã«ã¹)é°æ§èšŒææžãæåå®æ§æ€æ»ã®å Žåãæ€äœæ¡åãã24æé以å
ã®è£è¶³è³æãšããŠäºçŽæå»ã®ããŒãžãã³ããŒããOneHealthPassç»é²æžã¿ç»é¢ã»QRã³ãŒããã³ããŒãå»çä¿éº(æ°åã³ããæææã®æ²»çè²»35,000ãã«ãã«ãŒããŒ)ãæ瀺ãããã«ãŠã³ã¿ãŒã¹ã¿ããã«ãããšãOneHealthPassã®å
¥åãå¿ããŠãã人ã®å
¥åãæ¡å
ãããããŸãã«é°æ§èšŒæã®æéãéããŠããããšã§æä¹ã§ããªããªããã©ãã«ãçºçããŠããããã ã
ãã«ãŠã³ã¿ãŒã§ã®ãã§ãã¯ã¯5åã»ã©ãæç°ãŒããã©ãããã©ãŒã»ãã®2æã®æä¹åžãæã«ãããæ©æã¯ãšã¢ãã¹A321ã§ã199人ä¹ããçŽ100人ãæä¹äºå®ãæä¹çã¯çŽ50ïŒ
ã
ããã£ãªãã³ã®è¯ããšããã¯ãå°çæã®ç©ºæž¯ã§RT-PCRæ€æ»ããæåæ€æ»ã®å®æœããªããããæéã®ãã¹ãå°ãªãããšã ã
ãæ°åã³ãããè延ããåã¯ãæ¥æ¬åå°ããçŽè¡äŸ¿ãéèªãããŠãããäžæã¯ãæ¥æ¬ã®LCCãŸã§ããè·¯ç·ãä¿æããŠããææããã£ãããã£ãªãã³èªç©ºã¯ã2020幎3æ19æ¥ãŸã§ãæç°ããã¯æ¯æ¥2䟿ãã¯ã¿ã³ã»ã空枯ãžã®çŽè¡äŸ¿ãé£ãã§ããããç·šéïŒafã
ãæ¥æã2022幎04æ23æ¥(å) 09:30
ãæäŸãGlobal News Asia